The risk of developing prostate cancer in entacapone and levodopa/DDCI users compared to levodopa/DDCI users without entacapone - A nation-wide retrospective register-based study

29/05/2012
23/04/2024
EU PAS number:
EUPAS2612
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Study results
Study results

ER_9411_StudyReport_Version_1_0_signed

English (1.35 MB - PDF) View document
Study report
Other information
Publications
Study publications
Korhonen P, Kuoppamäki M, Prami T, Hoti F, Cristopher S, Ellmèn J, Aho V, Vahte…
ENCePP Seal
Signed code of conduct

ENCePP_Annex3_DeclarationSignaturePage

English (902.67 KB - PDF) View document
Signed code of conduct checklist

ENCePP_Annex2_Checklist

English (169.6 KB - PDF) View document

ENCePP_Annex2_ChecklistSignaturePage

English (640.72 KB - PDF) View document
Signed checklist for study protocols

ENCePPChecklistforStudyProtocolsSignaturePage

English (855.25 KB - PDF) View document

EUPAS2612-2625

English (193.4 KB - PDF) View document